NCT02320799

Brief Summary

The aim of this study is to conduct a 12-week IPT+TAU versus wait list TAU in a cohort of HIV+GBV+ women in Nyanza Province to relieve depression and PTSD and improve ARV adherence. This pilot study will provide data on the efficacy trends, acceptability and feasibility of our IPT intervention and will generate preliminary findings for an R01-funded intervention to test the intervention's efficacy for remediating the effects of GBV trauma on mental health and HIV-related outcomes. Hypothesis 1: IPT+ TAU will be more effective for reduction of depression and PTSD than TAU alone. Hypothesis 2: IPT+TAU will be acceptable and feasible.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
9 months until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

May 1, 2019

Status Verified

April 1, 2019

Enrollment Period

3.4 years

First QC Date

September 9, 2014

Last Update Submit

April 29, 2019

Conditions

Keywords

interpersonal psychotherapyHIVwomengender based violencemental healthafricakenyaglobal mental healthHIV treatment adherence

Outcome Measures

Primary Outcomes (1)

  • Depression, PTSD

    structured clinical interview: Composite International Diagnostic Interview (CIDI)

    Change from 0-12 weeks, 12-24 weeks and 24-36 weeks

Secondary Outcomes (2)

  • ARV adherence

    Change from 0-12 weeks, 12-24 weeks and 24-36 weeks

  • HIV viral load

    12 weeks, 24 weeks, 36 weeks

Other Outcomes (2)

  • cost analyses

    Cost: 12 weeks; benefits (DALYS and productivity): Change from 0-12 weeks, 12-24 weeks and 24-36 weeks

  • Neurocognitive outcomes

    Change from 0-12 weeks, 12-24 weeks and 24-36 weeks

Study Arms (2)

treatment as usual

ACTIVE COMPARATOR

Usual Clinic psychosocial treatment

Behavioral: treatment as usual

interpersonal psychotherapy

EXPERIMENTAL

Interpersonal Psychotherapy is an evidence-based structured, brief psychotherapy which focuses on improving relationships in order to improve mood and reduce anxiety.

Behavioral: interpersonal psychotherapy

Interventions

Interpersonal psychotherapy is an evidence based, structured, brief psychotherapy which improves relationships in order to improve mood and reduce anxiety

interpersonal psychotherapy

Clinic psychosocial treatment as usual

treatment as usual

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) HIV+ women enrolled at FACES-Kisumu; (2) Diagnosis with depression (MDD, dysthymia, minor depression) and PTSD secondary to GBV\* on the CIDI; (3) Ability to attend weekly therapy sessions and repeated measures; (4) Age greater than 18 years; (5) Ability to give informed consent.

You may not qualify if:

  • (1) Cognitive dysfunction requiring a higher level of care or compromising ability to participate in IPT\*\*; (2) severe thought or mood disorder symptoms requiring a higher level of care or interfering with ability to participate in IPT; (3) current drug and alcohol dependence requiring substance use treatment. Although PTSD is associated with substance abuse in EuroAmerican populations, a recent study of 5175 FACES patients found that over 80% of this LMIC population use no alcohol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Family AIDS Care Education and Services

Kisumu, Nyanza, Kenya

Location

Related Publications (3)

  • Meffert SM, Neylan TC, McCulloch CE, Blum K, Cohen CR, Bukusi EA, Verdeli H, Markowitz JC, Kahn JG, Bukusi D, Thirumurthy H, Rota G, Rota R, Oketch G, Opiyo E, Ongeri L. Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial. PLoS Med. 2021 Jan 11;18(1):e1003468. doi: 10.1371/journal.pmed.1003468. eCollection 2021 Jan.

  • Opiyo E, Ongeri L, Rota G, Verdeli H, Neylan T, Meffert S. Collaborative Interpersonal Psychotherapy for HIV-Positive Women in Kenya: A Case Study From the Mental Health, HIV and Domestic Violence (MIND) Study. J Clin Psychol. 2016 Aug;72(8):779-83. doi: 10.1002/jclp.22359. Epub 2016 Jul 27.

  • Onu C, Ongeri L, Bukusi E, Cohen CR, Neylan TC, Oyaro P, Rota G, Otewa F, Delucchi KL, Meffert SM. Interpersonal psychotherapy for depression and posttraumatic stress disorder among HIV-positive women in Kisumu, Kenya: study protocol for a randomized controlled trial. Trials. 2016 Feb 3;17:64. doi: 10.1186/s13063-016-1187-6.

MeSH Terms

Conditions

DepressionStress Disorders, Post-TraumaticPsychological Well-Being

Interventions

Interpersonal PsychotherapyTherapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorStress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPersonal Satisfaction

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Susan M Meffert, MD, MPH

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2014

First Posted

December 19, 2014

Study Start

September 1, 2015

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

May 1, 2019

Record last verified: 2019-04

Locations